5-(4-(2-(dimethylamino)ethyl)phenyl)-1-methyl-6-((1-phenylethyl)thio)-1H-pyrazolo[3,4-d]pyrimidin-4(5H)-one

ID: ALA4851376

PubChem CID: 164615012

Max Phase: Preclinical

Molecular Formula: C24H27N5OS

Molecular Weight: 433.58

Molecule Type: Unknown

Names and Identifiers

Canonical SMILES:  CC(Sc1nc2c(cnn2C)c(=O)n1-c1ccc(CCN(C)C)cc1)c1ccccc1

Standard InChI:  InChI=1S/C24H27N5OS/c1-17(19-8-6-5-7-9-19)31-24-26-22-21(16-25-28(22)4)23(30)29(24)20-12-10-18(11-13-20)14-15-27(2)3/h5-13,16-17H,14-15H2,1-4H3

Standard InChI Key:  KAVNICGGLWRNAF-UHFFFAOYSA-N

Molfile:  

 
     RDKit          2D

 31 34  0  0  0  0  0  0  0  0999 V2000
   32.4262  -14.7218    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   32.4251  -15.5413    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   33.1331  -15.9503    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   33.8428  -15.5408    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   33.8399  -14.7182    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   33.1313  -14.3129    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   31.7136  -15.9517    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   31.0029  -15.5379    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   31.0074  -17.1806    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   31.7154  -16.7685    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   31.0043  -14.7192    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   30.2912  -16.7698    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   30.2920  -15.9455    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   29.5083  -15.6900    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   29.0231  -16.3565    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   29.5070  -17.0237    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   29.2538  -17.8007    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   32.4232  -17.1766    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
   32.4237  -17.9938    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   33.1316  -18.4020    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   33.1270  -19.2175    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   33.8341  -19.6256    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   34.5426  -19.2165    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   34.5394  -18.3951    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   33.8318  -17.9907    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   31.7162  -18.4028    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   34.5461  -14.3069    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   35.2554  -14.7129    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   35.9615  -14.3016    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   36.6708  -14.7075    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   35.9584  -13.4844    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  6  1  1  0
  2  7  1  0
  7  8  1  0
  8 13  1  0
 12  9  1  0
  9 10  2  0
 10  7  1  0
  8 11  2  0
 12 13  2  0
 13 14  1  0
 14 15  2  0
 15 16  1  0
 16 12  1  0
 16 17  1  0
 10 18  1  0
 18 19  1  0
 19 20  1  0
 20 21  2  0
 21 22  1  0
 22 23  2  0
 23 24  1  0
 24 25  2  0
 25 20  1  0
 19 26  1  0
  5 27  1  0
 27 28  1  0
 28 29  1  0
 29 30  1  0
 29 31  1  0
M  END

Alternative Forms

1. Parent:

   

   ALA4851376

   ---

Molecule Features

Natural Product: No

Oral: No

Chemical Probe: No

Parenteral: No

Molecule Type: Unknown

Topical: No

First In Class: No

Black Box: No

Chirality: No

Availability: No

Prodrug: No

Calculated Properties

Molecular Weight: 433.58

Molecular Weight (Monoisotopic): 433.1936

AlogP: 4.08

#Rotatable Bonds: 7

Polar Surface Area: 55.95

Molecular Species: BASE

HBA: 7

HBD: ┄

#RO5 Violations: ┄

HBA (Lipinski): 6

HBD (Lipinski): ┄

#RO5 Violations (Lipinski): ┄

CX Acidic pKa: ┄

CX Basic pKa: 9.18

CX LogP: 4.71

CX LogD: 2.93

Aromatic Rings: 4

Heavy Atoms: 31

QED Weighted: 0.32

Np Likeness Score: -1.76

References

1. Huddle BC, Grimley E, Chtcherbinine M, Buchman CD, Takahashi C, Debnath B, McGonigal SC, Mao S, Li S, Felton J, Pan S, Wen B, Sun D, Neamati N, Buckanovich RJ, Hurley TD, Larsen SD..  (2021)  Development of 2,5-dihydro-4H-pyrazolo[3,4-d]pyrimidin-4-one inhibitors of aldehyde dehydrogenase 1A (ALDH1A) as potential adjuncts to ovarian cancer chemotherapy.,  211  [PMID:33341649] [10.1016/j.ejmech.2020.113060]

Source

Source(1):

• Scientific Literature